Novel vaccine technologies and strategies to promote sustained vaccine efficiency
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93018C00037
- Awardee
-
Profectus Biosciences, Inc. UEI DDRUDKNS37N8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $322,336
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Pre-Solicitation · PHS20181 · Posted Jun 29, 2017
- Contract value 100% obligated
- $322,336.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 238990 All Other Specialty Trade Contractors
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$127,664 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $450,000 |
About this award
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Profectus Biosciences, Inc., a small business concern, for the development of novel vaccine technologies and strategies. The contract has a total potential value of $322,336.00 and was awarded under the Small Business Innovation Research (SBIR) Program Phase I. The contract is a Definitive Contract with a Firm Fixed Price pricing type. The purpose is to conduct innovative research that will contribute to meeting the program objectives of HHS and NIH, specifically in the area of promoting sustained vaccine efficiency.
Quick answers
Who was awarded contract 75N93018C00037?
75N93018C00037 was awarded to Profectus Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 22, 2018.
How much is contract 75N93018C00037 worth?
The government has obligated $322,336 on 75N93018C00037.
Was contract 75N93018C00037 competed?
The extent of competition for 75N93018C00037 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award